Drug shortages homepage

Welcome to Drug Shortages Canada, the website for reporting drug shortages and discontinuations in Canada. The Food and Drug Regulations require drug sellers to report when they are not able to meet demand for a product or when they stop selling a product. Information about the website and the regulations can be found on the About & Resources Page.

A shortage means, in respect of a drug, a situation in which the manufacturer to whom a document was issued under subsection C.01.014.2(1) that sets out the drug identification number assigned for the drug is unable to meet the demand for the drug.

Below are the newest and most recently updated Shortage and Discontinuation reports.

Drug pills

Shortage Reports

Brand name Company Name Status Strength Update Date Updated View Report
IMITREX NASAL SPRAY GLAXOSMITHKLINE INC Anticipated shortage 20MG New Report 2019-04-18 82069
JAMP-ROPINIROLE JAMP PHARMA CORPORATION Actual shortage 5.0MG Updated Report 2019-04-18 30025
JAMP-ROPINIROLE JAMP PHARMA CORPORATION Actual shortage 5.0MG Updated Report 2019-04-18 64287
JAMP-ROPINIROLE JAMP PHARMA CORPORATION Actual shortage 1.0MG Updated Report 2019-04-18 64282
JAMP-PIOGLITAZONE JAMP PHARMA CORPORATION Actual shortage 15MG Updated Report 2019-04-18 70089
JAMP-PIOGLITAZONE JAMP PHARMA CORPORATION Actual shortage 45MG Updated Report 2019-04-18 30031
JAMP-PIOGLITAZONE JAMP PHARMA CORPORATION Actual shortage 30MG Updated Report 2019-04-18 30028
JAMP-OXCARBAZEPINE JAMP PHARMA CORPORATION Actual shortage 600MG Updated Report 2019-04-18 64276
JAMP-OXCARBAZEPINE JAMP PHARMA CORPORATION Actual shortage 300MG Updated Report 2019-04-18 64271
JAMP-OXCARBAZEPINE JAMP PHARMA CORPORATION Actual shortage 150MG Updated Report 2019-04-18 64268
JAMP-LOSARTAN JAMP PHARMA CORPORATION Actual shortage 25MG Updated Report 2019-04-18 64259
JAMP-LOSARTAN JAMP PHARMA CORPORATION Actual shortage 25MG Updated Report 2019-04-18 64256
JAMP-LEVETIRACETAM JAMP PHARMA CORPORATION Actual shortage 750MG Updated Report 2019-04-18 64250
JAMP-LEVETIRACETAM JAMP PHARMA CORPORATION Actual shortage 500MG Updated Report 2019-04-18 64240
JAMP-LEVETIRACETAM JAMP PHARMA CORPORATION Actual shortage 250MG Updated Report 2019-04-18 64233
JAMP-CANDESARTAN JAMP PHARMA CORPORATION Actual shortage 32MG Updated Report 2019-04-18 64208
JAMP-CANDESARTAN JAMP PHARMA CORPORATION Actual shortage 16MG Updated Report 2019-04-18 64203
JAMP-CANDESARTAN JAMP PHARMA CORPORATION Actual shortage 8MG Updated Report 2019-04-18 64195
ALVESCO ASTRAZENECA CANADA INC Anticipated shortage 100MCG Updated Report 2019-04-18 80526
DOSTINEX PFIZER CANADA ULC Actual shortage 0.5MG Updated Report 2019-04-18 73569

Discontinuation Reports

Brand name Company Name Status Strength Update Date Updated View Report
STATEX SYRUP 1MG/ML PALADIN LABS INC To be discontinued 1MG New Report 2019-04-18 81996
STATEX DPS 50MG/ML PALADIN LABS INC Discontinued Updated Report 2019-04-18 81954
RIVA-OLMESARTAN LABORATOIRE RIVA INC Discontinued 20MG Updated Report 2019-04-18 81926
RIVA-OLMESARTAN LABORATOIRE RIVA INC Discontinued 40MG Updated Report 2019-04-18 81929
ULTRAVIST 240 BAYER INC Discontinued 50% New Report 2019-04-17 81959